<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36806073</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>17</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT).</ArticleTitle><Pagination><StartPage>e071261</StartPage><MedlinePgn>e071261</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e071261</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2022-071261</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The impact of long COVID on health-related quality of-life (HRQoL) and productivity is not currently known. It is important to understand who is worst affected by long COVID and the cost to the National Health Service (NHS) and society, so that strategies like booster vaccines can be prioritised to the right people. OpenPROMPT aims to understand the impact of long COVID on HRQoL in adults attending English primary care.</AbstractText><AbstractText Label="METHODS AND ANALYSIS">We will ask people to participate in this cohort study through a smartphone app (Airmid), and completing a series of questionnaires held within the app. Questionnaires will ask about HRQoL, productivity and symptoms of long COVID. Participants will be asked to fill in the questionnaires once a month, for 90 days. Questionnaire responses will be linked, where possible, to participants' existing health records from primary care, secondary care, and COVID testing and vaccination data. Analysis will take place using the OpenSAFELY data platform and will estimate the impact of long COVID on HRQoL, productivity and cost to the NHS.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">The Proportionate Review Sub-Committee of the South Central-Berkshire B Research Ethics Committee has reviewed and approved the study and have agreed that we can ask people to take part (22/SC/0198). Our results will provide information to support long-term care, and make recommendations for prevention of long COVID in the future.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER">NCT05552612.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Herrett</LastName><ForeName>Emily</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9425-644X</Identifier><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, London, UK emily.herrett@lshtm.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomlin</LastName><ForeName>Keith</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Liang-Yu</ForeName><Initials>LY</Initials><Identifier Source="ORCID">0000-0003-4720-6738</Identifier><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomlinson</LastName><ForeName>Laurie A</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0001-8848-9493</Identifier><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jit</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6658-8255</Identifier><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briggs</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marks</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7585-4743</Identifier><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital for Tropical Diseases, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandmann</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parry</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>TPP, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bates</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>TPP, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morley</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5221-4770</Identifier><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bacon</LastName><ForeName>Seb</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler-Cole</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahalingasivam</LastName><ForeName>Viyaasan</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dennison</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Patient and Public Involvement Steering Committee, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Deb</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Patient and Public Involvement Steering Committee, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabriel</LastName><ForeName>Ethan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Patient and Public Involvement Steering Committee, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehrkar</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldacre</LastName><ForeName>Ben</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-5127-4728</Identifier><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smeeth</LastName><ForeName>Liam</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eggo</LastName><ForeName>Rosalind M M</ForeName><Initials>RMM</Initials><Identifier Source="ORCID">0000-0002-0362-6717</Identifier><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05552612</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>MR/W016729/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>222097/Z/20/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/V015757/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20051</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/V015737/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20030</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20058</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20059</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC-20059</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="N">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063731" MajorTopicYN="Y">Mobile Applications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071066" MajorTopicYN="N">Patient Reported Outcome Measures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068997" MajorTopicYN="N">Smartphone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013222" MajorTopicYN="N">State Medicine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">HEALTH ECONOMICS</Keyword><Keyword MajorTopicYN="N">Quality of Life</Keyword></KeywordList><CoiStatement>Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare the following: BG has received research funding from the Laura and John Arnold Foundation, the NHS National Institute for Health Research (NIHR), the NIHR School of Primary Care Research, NHS England, the NIHR Oxford Biomedical Research Centre, the Mohn-Westlake Foundation, NIHR Applied Research Collaboration Oxford and Thames Valley, the Wellcome Trust, the Good Thinking Foundation, Health Data Research UK, the Health Foundation, the World Health Organisation, UKRI MRC, Asthma UK, the British Lung Foundation, and the Longitudinal Health and Wellbeing strand of the National Core Studies programme; he is a non-executive director at NHS Digital; he also receives personal income from speaking and writing for lay audiences on the misuse of science. DS has a zero hours contract with NHS Digital, NHS Health Education West Midlands and the Usher Institute at Edinburgh University, and is part of the patient panel for the British Society of Immunology and the Wales COVID Evidence Centre. MJ has received funding from NIHR, MRC, Wellcome Trust, BMGF, WHO, Gavi and US CDC.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36806073</ArticleId><ArticleId IdType="pmc">PMC9943695</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2022-071261</ArticleId><ArticleId IdType="pii">bmjopen-2022-071261</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Franco JVA, Garegnani LI, Oltra GV, et al. . Long-Term health symptoms and sequelae following SARS-cov-2 infection: an evidence MAP. Int J Environ Res Public Health 2022;19:9915. 10.3390/ijerph19169915</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19169915</ArticleId><ArticleId IdType="pmc">PMC9408764</ArticleId><ArticleId IdType="pubmed">36011562</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19 [NICE]. 2021. Available: https://www.nice.org.uk/guidance/ng188</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-Dimensional characterization of post-acute sequelae of COVID-19. Nature 2021;594:259&#x2013;64. 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson KB, Rao M, Bonilla H, et al. . Patients with uncomplicated coronavirus disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin Infect Dis 2021;73:e826&#x2013;9. 10.1093/cid/ciab103</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab103</ArticleId><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker HR, Gulea C, Koteci A, et al. . Post-Acute COVID-19 sequelae in cases managed in the community or hospital in the UK: a population based study. SSRN Journal 2021. 10.2139/ssrn.3820510 Available: 10.2139/ssrn.3820510</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3820510</ArticleId><ArticleId IdType="doi">10.2139/ssrn.3820510</ArticleId><ArticleId IdType="pmc">PMC8715128</ArticleId><ArticleId IdType="pubmed">34965929</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK - office for national statistics. 2022. 
Available: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/3november2022</Citation></Reference><Reference><Citation>de Oliveira Almeida K, Nogueira Alves IG, de Queiroz RS, et al. . A systematic review on physical function, activities of daily living and health-related quality of life in COVID-19 survivors. Chronic Illn 2022:17423953221089309. 10.1177/17423953221089309</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17423953221089309</ArticleId><ArticleId IdType="pmc">PMC9006095</ArticleId><ArticleId IdType="pubmed">35404175</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, Patel K, Pinto C, et al. . Post-Acute COVID-19 syndrome (PCS) and health-related quality of life (hrqol) -A systematic review and meta-analysis. J Med Virol 2022;94:253&#x2013;62. 10.1002/jmv.27309</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandasena HMRKG, Pathirathna ML, Atapattu AMMP, et al. . Quality of life of COVID 19 patients after discharge: systematic review. PLOS ONE 2022;17:e0263941. 10.1371/journal.pone.0263941</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0263941</ArticleId><ArticleId IdType="pmc">PMC8849513</ArticleId><ArticleId IdType="pubmed">35171956</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, et al. . Risk of long COVID associated with delta versus omicron variants of SARS-cov-2. Lancet 2022;399:2263&#x2013;4. 10.1016/S0140-6736(22)00941-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-cov-2 reinfection. Nat Med 2022;28:2398&#x2013;405. 10.1038/s41591-022-02051-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Airmid . TPP. 2020. Available: https://tpp-uk.com/products/airmid/</Citation></Reference><Reference><Citation>EQ-5D. n.d.
Available: https://euroqol.org/</Citation></Reference><Reference><Citation>Reilly M. n.d. Work productivity and activity impairment questionnaire. :2.</Citation></Reference><Reference><Citation>MRC dyspnoea scale . Primary care respiratory society. n.d.
Available: https://www.pcrs-uk.org/mrc-dyspnoea-scale</Citation></Reference><Reference><Citation>FACIT-F . FACIT group. n.d.
Available: https://www.facit.org/measures/FACIT-F</Citation></Reference><Reference><Citation>Andrews C, Schultze A, Curtis H, et al. . OpenSAFELY: representativeness of electronic health record platform opensafely-TPP data compared to the population of england. Wellcome Open Res
2022;7:191. 10.12688/wellcomeopenres.18010.1
Available: https://wellcomeopenresearch.org/articles/7-191/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.18010.1</ArticleId><ArticleId IdType="pmc">PMC9346309</ArticleId><ArticleId IdType="pubmed">35966958</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M, Moreno E, Cari&#xf1;ena A, et al. . Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients. Br J Anaesth 2021;126:e110&#x2013;3. 10.1016/j.bja.2020.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.12.007</ArticleId><ArticleId IdType="pmc">PMC7833644</ArticleId><ArticleId IdType="pubmed">33413976</ArticleId></ArticleIdList></Reference><Reference><Citation>Ping W, Zheng J, Niu X, et al. . Evaluation of health-related quality of life using EQ-5D in China during the COVID-19 pandemic. PLOS ONE 2020;15:e0234850. 10.1371/journal.pone.0234850</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0234850</ArticleId><ArticleId IdType="pmc">PMC7302485</ArticleId><ArticleId IdType="pubmed">32555642</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK - office for national statistics. 2022. 
Available: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/7april2022</Citation></Reference><Reference><Citation>Long COVID and the labour market. Institute for Fiscal Studies. n.d.
Available: https://ifs.org.uk/publications/long-covid-and-labour-market</Citation></Reference><Reference><Citation>OpenSAFELY long COVID study website. n.d.
Available: https://www.opensafely.org/studies/long-covid/</Citation></Reference><Reference><Citation>OpenSAFELY: policies for researchers. n.d.
Available: https://www.opensafely.org/policies-for-researchers/</Citation></Reference><Reference><Citation>NHS england&#x202f;&#xbb; opensafely &#x2013; the coronavirus (COVID-19) research platform. n.d.
Available: https://www.england.nhs.uk/contact-us/privacy-notice/how-we-use-your-information/covid-19-response/coronavirus-covid-19-research-platform/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>